ENO2 and neuroendocrine neoplasm: Meanwhile, we did not find any association between NSE and the risk of BM, and this may be because NSE is a glycolytic enzyme that is commonly expressed in neuroendocrine tumors, particularly SCLC, rather than NSCLC.